A&C is a global GMP manufacturer of excipients, buffers, process solutions and a select number of active pharmaceutical ingredients (APIs). We have been servicing the life science industry since 1966, and expanded our footprint globally through the years. We currently have offices and GMP production facilities in North America and Europe.

We are a service driven organization finding unique solutions to our customers’ GMP challenges. We are a privately owned company where flexibility, transparency and quality are at the core of all of our activities. This is demonstrated through the numerous quality certifications that A&C holds:

  • ISO 9001:2015
  • EXCiPACT GMP and GDP for excipients
  • Drug Establishment Licence for manufacture of APIs
  • FDA and Health Canada audited

We remain committed to ensuring adherence to GMP and GDP and full compliance in meeting the international regulatory requirements which are key for our business decisions.

A&C works with a variety of products at our three GMP manufacturing facilities. We began with custom manufacturing of high purity solutions in 1966. The applications of our products include injectable, dermal, nasal, ophthalmic applications, preservatives, pH adjusters, cleaning solutions, solvents, flavours and aromatic compounds, lubricants, binders, antioxidants, process solutions and buffers. We offer GMP customized services for all our excipients and raw materials, including GMP custom ingredient development, GMP manufacturing and GMP custom packaging available in a wide range of FDA approved formats.


In 2019, A&C became member of two separate Canadian biotech associations named BIOTECanada and BioAlberta.


In 2018, we received the ISO 9001:2015 certification and a Certificate of Suitability (CEP) for 2-Phenoxyethanol API grade awarded by EDQM.


The expansion into Europe continued in 2017 with the opening of A&C Bio Buffer and a new state-of-the-art manufacturing facility in Limerick, Ireland


In 2016 we built our second EXCiPACT and ISO certified GMP manufacturing facility in Baie-D’Urfé, Canada.


In 2015 we expanded into Europe and opened new offices in Ireland. Since 2015, we have been holding the Drug Establishment Licence for API manufacturing, labelling, testing and distribution issued by Health Canada.


In 2014 we received the EXCiPACT certification for GMP and GDP. We were the first excipient manufacturer in North America to receive the certification from this world renowned accreditation body. In that same year, we completed our registration with FDA for pharmaceutical ingredient manufacturing and we received FDA approval.


We received the ISO 9001:2008 certification in 2012, showing continuous commitment to quality, one of the core values of our company.


In 2011 we completed all GMP facility renovations, as well as GDP warehousing at a second manufacturing site in Canada. A&C United States was launched and we opened a new sales office in North Carolina


In 2008, we held the first Ph. Eur 6th Edition training session in Canada with EDQM (European Directorate for the Quality of Medicines) which demonstrated our continuous focus and commitment on keeping high quality standards.


In 2007, A&C continued our expansion and upgraded towards GMP environment for both our new and existing products.


In 2006 we hosted the first USP Educational Forum Conference in Montreal. Keeping quality at the core of our business, in that same year, we successfully registered USDMF for Azelastine HCL with FDA, which included an FDA audit, a DMF review, and a Manufacturer approval.


In 1990, buffer and cleaning solutions were introduced to the product range which led to a plant expansion as production and warehouse doubled.


In 1975, following the distribution of USP Reference Standards, A&C proudly became the oldest USP distributor worldwide.


Our first facility was built in Montreal, Canada in 1966 to accommodate an increase in sales and to allow new product development and growth. For over 25 years the business continued to grow yearly mainly with fine chemicals and laboratory chemical manufacturing.